InspireMD has announced that it has completed enrollment in the MASTER (MGuard™ for Acute ST Elevation Reperfusion) trial and is on track to release preliminary top line results in the third quarter of 2012.
Stents
Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
According to study results presented at the American Association of Clinical Endocrinologists (AACE) 21st Annual Scientific and Clinical Congress in Philadelphia, Medtronic’s Resolute® drug-eluting stent (DES) from Medtronic, Inc. yields strong performance in coronary artery disease (CAD) patients both with and without diabetes through two years of follow-up.
PLATINUM Study: PROMUS Element™ Stent Demonstrates Impressive Long Term results In Small Vessels
Boston Scientific Corporation took the opportunity presented by EuroPCR to announce “excellent” two-year results from the PLATINUM Small Vessel study.
Bioabsorbable Magnesium Scaffold Stent Results Suggest Restoration Of Vessel’s Natural Architecture
Biotronik’s press department was in overdrive at EuroPCR last week, announcing that twelve-month results from the BIOSOLVE-I study with the DRug Eluting Absorbable Metal Scaffold (DREAMS) demonstrate safety and confirm vessel vasomotion.
Study Suggests Stents Coated With Endothelial Progenitor Cell Capture Antibody Improves Neointimal Appearance At 9 Months
Not satisfied with just drug elution as a means of reducing neointimal hyperplasia, OrbusNeich has built in an Endothelial Progenitor Cell capture coating which appears in this blinded study to improve neointimal appearance at 9 months.
New EU Min Three-Month Anti-Platelet Indication A First For Abbott’s XIENCE PRIME™ and XIENCE V® Drug Eluting Stents
Dual anti-platelet therapy is normally required for 6-12 months after implantation of a stent, with associated risks, costs and general inconvenience. No wonder then that Abbott is sounding pleased with itself as it gains the first indication of its kind to reduce the therapeutic period to a minimum of 3 months based on data from 10,000 patients.
CE Mark and EU Launch Of Boston Scientific’s Innova™ Self-expanding Bare-Metal Peripheral Vascular Stent
Boston Scientific Corporation has issued an announcement confirming CE Mark approval and European market launch of the Innova™ Self-Expanding Bare-Metal Stent System, which is designed to treat peripheral vascular lesions in arteries above the knee.
Stent Blog Nails Publication Over “Thinly Disguised Marketing Studies”
When is a published paper a thinly disguised marketing study? One man clearly has a view.
Bioabsorbable Stent Data Says It’s Safe At 10 Years
Bioabsorbable stents are back in the news with the publication of ten year data from Japan claiming safety at ten years in a 50 patient study.
Japanese Approval For Abbott’s XIENCE PRIME™ Drug Eluting Stent
Achieving device approval in Japan is a major undertaking, so Abbott must be delighted that its Xience Prime everolimus eluting stent has got the nod based on a robust body of clinical evidence.
Genous™ “Pro-healing” Stent Feasible And Safe In STEMI Patients, According To Study Presented At ACC
OrbusNeich has issued a news release about a clinical study which supports the company’s claim that its clever “pro-healing” stent technology results in a stent which can be indicated in STEMI patients.
Pathologist Highlights Question Of Stent Sizing. Could The Stentys Self-Apposing™ Device Be The Answer?
Stent company Stentys reckons its self-expanding product addresses a problem raised in acute myocardial application of existing designs.
Everolimus Shines As Meta-Analysis Suggests Lower Thrombosis Rates Than Others
Everolimus stents appear top dog in long term stent thrombosis meta-analysis.
Is FDA About To Clip Stryker’s Wingspan?
Stryker’s Wingspan Stent is up for FDA panel review on March 23rd. FDA’s Executive Summary, released today doesn’t auger well as results of clinical study don’t seem to support safety and efficacy claims.
Cook’s Zilver® PTX™Peripheral Stent Gains Australian Approval
Vascular Surgeons in Australia now have access to a new technology, with the approval of Cook Medical’s Zilver PTX drug-eluting stent for treatment of peripheral artery disease.
Blue Medical Trumpets New Drug-Eluting Balloon/Stent Combination
Using a Drug-coated balloon to implant a bare metal stent might just be a smart idea, at least according to Dutch Cardiovascular specialists Blue Medical in announcing the launch of their innovative new offering.